Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line

Murray Korc, C. A. Haussler, N. S. Trookman

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Epidermal growth factor (EGF), at concentrations ranging from 0.83 to 4.98 nM, markedly inhibited the proliferation of RL95-2 cells that were seeded at low plating densities (4.7 x 103 cells/cm2). Under the same incubation conditions, 16.6 pM EGF enhanced cell proliferation. At high plating densities (2.5 x 104 cells/cm2) 0.83 nM EGF also stimulated cell proliferation. Both the inhibitory and stimulatory effects of EGF were mimicked by transforming growth factor-α (TGF-α). However, the inhibitory action of TGF-α was always greater than that of EGF. Binding studies with 125I-labeled TGF-α indicated that maximal cell surface binding of TGF-α occurred at 15 min, whereas maximal internalization occurred at 45 min. Both cell surface and internalized radioactivity declined sharply thereafter. Analysis of radioactivity released into the incubation medium during pulse-chase experiments indicated that RL95-2 cells extensively degraded both TGF-α and EGF. The lysosomotropic compound methylamine arrested the generation of low-molecular-weight degradation products of EGF, but not of TGF-α. In contrast to EGF and TGF-α, transforming growth factor-β (TGF-β) inhibited the proliferation of RL95-2 cells that were seeded at either low or high plating densities. Further, transforming growth factor-β induced the appearance of large cuboidal cells that were readily distinguished from cells treated with either EGF or TGF-α. These findings point to complex regulatory actions of growth factors on the proliferation of RL95-2 cells and suggest that the processing of TGF-α following EGF receptor activation is distinct from the processing of EGF.

Original languageEnglish (US)
Pages (from-to)4909-4914
Number of pages6
JournalCancer Research
Volume47
Issue number18
StatePublished - 1987
Externally publishedYes

Fingerprint

Transforming Growth Factors
Endometrial Neoplasms
Epidermal Growth Factor
Cell Line
Radioactivity
Cell Proliferation
Epidermal Growth Factor Receptor
Intercellular Signaling Peptides and Proteins
Molecular Weight

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. / Korc, Murray; Haussler, C. A.; Trookman, N. S.

In: Cancer Research, Vol. 47, No. 18, 1987, p. 4909-4914.

Research output: Contribution to journalArticle

Korc, Murray ; Haussler, C. A. ; Trookman, N. S. / Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. In: Cancer Research. 1987 ; Vol. 47, No. 18. pp. 4909-4914.
@article{048a0ebb5d064c668d5153ed2507ac5a,
title = "Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line",
abstract = "Epidermal growth factor (EGF), at concentrations ranging from 0.83 to 4.98 nM, markedly inhibited the proliferation of RL95-2 cells that were seeded at low plating densities (4.7 x 103 cells/cm2). Under the same incubation conditions, 16.6 pM EGF enhanced cell proliferation. At high plating densities (2.5 x 104 cells/cm2) 0.83 nM EGF also stimulated cell proliferation. Both the inhibitory and stimulatory effects of EGF were mimicked by transforming growth factor-α (TGF-α). However, the inhibitory action of TGF-α was always greater than that of EGF. Binding studies with 125I-labeled TGF-α indicated that maximal cell surface binding of TGF-α occurred at 15 min, whereas maximal internalization occurred at 45 min. Both cell surface and internalized radioactivity declined sharply thereafter. Analysis of radioactivity released into the incubation medium during pulse-chase experiments indicated that RL95-2 cells extensively degraded both TGF-α and EGF. The lysosomotropic compound methylamine arrested the generation of low-molecular-weight degradation products of EGF, but not of TGF-α. In contrast to EGF and TGF-α, transforming growth factor-β (TGF-β) inhibited the proliferation of RL95-2 cells that were seeded at either low or high plating densities. Further, transforming growth factor-β induced the appearance of large cuboidal cells that were readily distinguished from cells treated with either EGF or TGF-α. These findings point to complex regulatory actions of growth factors on the proliferation of RL95-2 cells and suggest that the processing of TGF-α following EGF receptor activation is distinct from the processing of EGF.",
author = "Murray Korc and Haussler, {C. A.} and Trookman, {N. S.}",
year = "1987",
language = "English (US)",
volume = "47",
pages = "4909--4914",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line

AU - Korc, Murray

AU - Haussler, C. A.

AU - Trookman, N. S.

PY - 1987

Y1 - 1987

N2 - Epidermal growth factor (EGF), at concentrations ranging from 0.83 to 4.98 nM, markedly inhibited the proliferation of RL95-2 cells that were seeded at low plating densities (4.7 x 103 cells/cm2). Under the same incubation conditions, 16.6 pM EGF enhanced cell proliferation. At high plating densities (2.5 x 104 cells/cm2) 0.83 nM EGF also stimulated cell proliferation. Both the inhibitory and stimulatory effects of EGF were mimicked by transforming growth factor-α (TGF-α). However, the inhibitory action of TGF-α was always greater than that of EGF. Binding studies with 125I-labeled TGF-α indicated that maximal cell surface binding of TGF-α occurred at 15 min, whereas maximal internalization occurred at 45 min. Both cell surface and internalized radioactivity declined sharply thereafter. Analysis of radioactivity released into the incubation medium during pulse-chase experiments indicated that RL95-2 cells extensively degraded both TGF-α and EGF. The lysosomotropic compound methylamine arrested the generation of low-molecular-weight degradation products of EGF, but not of TGF-α. In contrast to EGF and TGF-α, transforming growth factor-β (TGF-β) inhibited the proliferation of RL95-2 cells that were seeded at either low or high plating densities. Further, transforming growth factor-β induced the appearance of large cuboidal cells that were readily distinguished from cells treated with either EGF or TGF-α. These findings point to complex regulatory actions of growth factors on the proliferation of RL95-2 cells and suggest that the processing of TGF-α following EGF receptor activation is distinct from the processing of EGF.

AB - Epidermal growth factor (EGF), at concentrations ranging from 0.83 to 4.98 nM, markedly inhibited the proliferation of RL95-2 cells that were seeded at low plating densities (4.7 x 103 cells/cm2). Under the same incubation conditions, 16.6 pM EGF enhanced cell proliferation. At high plating densities (2.5 x 104 cells/cm2) 0.83 nM EGF also stimulated cell proliferation. Both the inhibitory and stimulatory effects of EGF were mimicked by transforming growth factor-α (TGF-α). However, the inhibitory action of TGF-α was always greater than that of EGF. Binding studies with 125I-labeled TGF-α indicated that maximal cell surface binding of TGF-α occurred at 15 min, whereas maximal internalization occurred at 45 min. Both cell surface and internalized radioactivity declined sharply thereafter. Analysis of radioactivity released into the incubation medium during pulse-chase experiments indicated that RL95-2 cells extensively degraded both TGF-α and EGF. The lysosomotropic compound methylamine arrested the generation of low-molecular-weight degradation products of EGF, but not of TGF-α. In contrast to EGF and TGF-α, transforming growth factor-β (TGF-β) inhibited the proliferation of RL95-2 cells that were seeded at either low or high plating densities. Further, transforming growth factor-β induced the appearance of large cuboidal cells that were readily distinguished from cells treated with either EGF or TGF-α. These findings point to complex regulatory actions of growth factors on the proliferation of RL95-2 cells and suggest that the processing of TGF-α following EGF receptor activation is distinct from the processing of EGF.

UR - http://www.scopus.com/inward/record.url?scp=0023199917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023199917&partnerID=8YFLogxK

M3 - Article

C2 - 3497713

AN - SCOPUS:0023199917

VL - 47

SP - 4909

EP - 4914

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -